SCHEMBL322722

SCHEMBL322722

O=CC(c1ccc(Cl)cc1)N1CCN(c2ncnc3[nH]ccc23)CC2(CC2)C1

nearest known ligand 0.54

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 17/20 0.54
AKT2 P31751 11/20 0.54
ROCK2 O75116 8/20 0.54
AKT3 Q9Y243 8/20 0.54
KCNH2 Q12809 6/20 0.54
GSK3B P49841 3/20 0.52
KIT P10721 1/20 0.51
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
RPS6KB1 P23443 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL325110 0.92 AKT1 (0.53) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL324613 0.92 JAK3 (0.53) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL323781 0.92 JAK3 (0.53) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL323241 0.92 JAK3 (0.46) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL324666 0.91 JAK3 (0.52) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL323886 0.89 AKT2 (0.51) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL324306 0.89 KIT (0.52) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL324213 0.89 JAK3 (0.55) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL323926 0.89 AKT1 (0.55) AKT1AKT2ROCK2AKT3KCNH2
SCHEMBL324757 0.88 AKT1 (0.56) AKT1AKT2ROCK2AKT3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590981-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF Leo Pharma A/S (DK) 2013-05-15 EP disclosed
WO-2012003829-A1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA A/S (DK) 2012-01-12 WO disclosed